AC

Accolade IncNASDAQ ACCD Stock Report

Last reporting period 31 Aug, 2024

Updated 22 Nov, 2024

Last price

Market cap $B

0.314

Micro

Exchange

XNAS - Nasdaq

ACCD Stock Analysis

AC

Uncovered

Accolade Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-11/100

Low score

Market cap $B

0.314

Dividend yield

Shares outstanding

72.787 B

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that contract with Accolade to provide their employees and their employees’ families (the members) a single place to turn for their health, healthcare, and benefits needs. The company also offers virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Core and Plus, and Accolade One.

View Section: Eyestock Rating